Stock screener

ACOG

Conviction 90HealthcareScan · Mon, Aug 10, 2026
Bearish harami
ACOG$8.87-2.85%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 124.01K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Alpha Cognition Inc.Biological Products, (No Diagnostic Substances)www.alphacognition.com
Price8.87
Change-2.85%
Gap-1.31%
Rel volume2.73×
Avg volume112.31K
Avg $ vol941.45K
SMA 208.44
SMA 507.47
SMA 2006.32
Price vs 50+18.77%
Price vs 200+40.31%
MA stackbullish
50/200 cross
Supertrendup · 7.08
RSI (14)59
MACD hist-0.01
MACD cross
Stoch %K / %D77 / 79
ADX (14)16
+DI / −DI18 / 11
RSI divergenceBearish
MACD divergenceBearish
ATR %+7.96%
ADR %9.04%
52w high9.99
52w low4.50
From 52w high-11.21%
Above 52w low+97.11%
New 52w highNo
SqueezeOn · 9d
Bollinger width16.26%
%B0.81
Donchian pos78.02%
Donchian high9.27
Donchian low7.45
AVWAP (52w high)6.76
vs AVWAP high+31.12%
AVWAP (52w low)6.75
vs AVWAP low+31.41%
OBV trendFlat
Chaikin MF (20)-0.10
Today vs 20d2.73×
Avg vol (14d)124.01K
Avg vol (20d)112.31K
Avg $ vol (20d)941.45K
Market cap193.14M
RS 3m (vs SPY)+44.22%
RS 6m (vs SPY)+88.77%
RS line new highNo
Trend template8/8
Technical rank89.2
1 week+5.22%
1 month+5.47%
3 months+45.41%
6 months+73.92%
1 year-2.85%
YTD+36.46%
P/E-9.34
P/B3.36
P/S18.90
P/FCF-9.34
EPS-1.18
Div yield
ROE-35.97%
ROA-29.85%
Debt/Eq
Current12.64
EV/EBITDA-6.14
Gross margin
Net margin-202.24%
Rev growth
EPS growth-39.77%
Price target
Target upside
Analyst rating
Institutional
Ent. value138.89M
Revenue3.53M
Net income-6.48M
Gross profit
Free cash flow-20.67M
IndustryBiological Products, (No Diagnostic Substances)
ExchangeNasdaq
Shares out21.77M
Employees71
ListedWed, Jun 9, 2021
Free float19.08M
Float %87.8%
Short interest215.58K
Days to cover3.5d
Short volume52.9%
Squeeze score43 / 100
Next earningsThu, Aug 13, 2026 · after (3d)
EPS forecast−$0.39 · 3 est
Last EPS vs est−$0.37 vs −$0.41
Last surprise+9.8% beat
Setup gradeA+
Conviction90 / 100
Pattern quality
Tech rank89.2 / 100
Group rank
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBearish harami
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACOG

All disclosures →
No recent disclosed trades by Congress in ACOG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACOG · 8 buys

InsiderSideShares
Opaleye Management Inc.
10% owner · Common Stock, no par value · 2026-07-24
Buy130
Opaleye Management Inc.
10% owner · Common Stock, no par value · 2026-06-26
Buy152.34K
Opaleye Management Inc.
10% owner · Common Stock, no par value · 2026-06-25
Buy197
Opaleye Management Inc.
10% owner · Common Stock, no par value · 2026-06-05
Other
Opaleye Management Inc.
10% owner · Common Stock, no par value · 2026-06-05
Buy10.05K
Opaleye Management Inc.
10% owner · Common Stock, no par value · 2026-05-29
Buy70.58K
Opaleye Management Inc.
10% owner · Common Stock, no par value · 2026-05-28
Buy2K
Opaleye Management Inc.
10% owner · Common Stock, no par value · 2026-05-27
Buy1.16K
Opaleye Management Inc.
10% owner · Common Stock, no par value · 2026-05-27
Other
Opaleye Management Inc.
10% owner · Common Stock, no par value · 2026-05-21
Buy15.95K

SEC filings

EDGAR filings in ACOG · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.